-
Ask Amy: Child-free woman struggles with her friendships with parents
She doesn’t have children and finds it’s exhausting to maintain relationships with her friends who do.
-
German Court Invalidates CureVac Patent in Ongoing BioNTech Lawsuit
On December 19, a German court invalidated CureVac’s messenger RNA technology patent, EP 1 857 122 B1, in a lawsuit brought by CureVac against its rival BioNTech……By: Goodwin
-
Breaking: Judgment in Regeneron v. Mylan (aflibercept) BPCIA Case Finding Some Claims of Asserted Patents Valid and Infringed
As previously reported by Big Molecule Watch, trial in Regeneron’s BPCIA case against Biocon regarding Biocon’s proposed aflibercept biosimilar concluded on June 15, 2023 in the Northern District of West Virginia. The patents-at-issue are directed to formulations and dosing regimens for aflibercept, an anti-VEGF treatment for retinal disorders including age-related macular degeneration, diabetic macular edema,…
-
Guidance from European Data Protection Board Requires Consent for Tracking
The European Data Protection Board (EDPB), a board comprised primarily of representatives of the data protection supervisory authorities of the European Union’s member states, issued surprising new guidance in mid-November explaining how a key component of the European Union’s ePrivacy Directive applies to variety of commonly used technologies used for tracking on the internet….By: Dorsey…
-
Year in Review: Top Deals in 2023
According to PWC, “2023 was a reasonably strong year for the pharmaceutical and life sciences sector with both deal value and volume of M&A close to pre-pandemic levels.” Below is a recap of the top M&A deals in 2023 that focus on biologics and biosimilars and were covered on the Big Molecule Watch….By: Goodwin
-
UCB, Inc. v. Annora Pharma Priv. Ltd. – Briviact® (Brivaracetam)
Case Name: UCB, Inc. v. Annora Pharma Priv. Ltd., Civ. No. 20-987-CFC, 2023 WL 5274566 (D. Del. Aug. 16, 2023) (Connolly, J.) – Drug Product and Patent(s)-in-Suit: Briviact® (brivaracetam); U.S. Patent No. 6,911,461 (“the ’461 patent”)….By: Robins Kaplan LLP
-
Michigan Court of Appeals Expands Unlawful Taking Rule
Under the Michigan No-Fault Act certain situations will disqualify a person from receiving Personal Injury Protection/Personal Protection Insurance (“PIP”) benefits….By: Segal McCambridge
-
Brunswick Corporation Files Official Notice of June 2023 Data Breach
On December 20, 2023, Brunswick Corporation (“Brunswick”) filed a notice of data breach with the Attorney General of Massachusetts after discovering that a June 2023 data security incident compromised sensitive information belonging to certain employees and customers. In this notice, Brunswick explains that the incident resulted in an unauthorized party being able to access consumers’…
-
Sharonview Federal Credit Union Announces Data Breach Following Unauthorized Access to Employee’s Email Account
On December 4, 2023, Sharonview Federal Credit Union (“Sharonview”) filed a notice of data breach with the Attorney General of Massachusetts after discovering that an unauthorized party was able to access an employee’s email account. In this notice, Sharonview explains that the incident resulted in an unauthorized party being able to access consumers’ sensitive information,…
-
Meridian Behavioral Healthcare Notifies Patients of August 2023 Data Breach Impacting Their SSNs
On December 22, 2023, Meridian Behavioral Healthcare, Inc. (“Meridian”) filed a notice of data breach with the Attorney General of Massachusetts after discovering unauthorized activity within its computer system. In this notice, Meridian explains that the incident resulted in an unauthorized party being able to access patients’ sensitive information, which includes their names, addresses, Social…
